-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UbSWfaFbtLBujOy8Y35Zr6d8uJ2+eqdTW1bT6Z0GqewG8vxhz9gxDTMNyyvOBoZK pZ1Oz2n6aEpNjylPgOn7rw== 0001193125-04-008189.txt : 20040123 0001193125-04-008189.hdr.sgml : 20040123 20040123145821 ACCESSION NUMBER: 0001193125-04-008189 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20040122 ITEM INFORMATION: Financial statements and exhibits ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20040123 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MICROSEMI CORP CENTRAL INDEX KEY: 0000310568 STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674] IRS NUMBER: 952110371 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-08866 FILM NUMBER: 04540414 BUSINESS ADDRESS: STREET 1: 2381 MORSE AVENUE CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 7149798220 FORMER COMPANY: FORMER CONFORMED NAME: MICROSEMICONDUCTOR CORP DATE OF NAME CHANGE: 19830323 8-K 1 d8k.htm FORM 8-K FOR MICROSEMI CORPORATION FORM 8-K for MICROSEMI CORPORATION

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 8-K

 


 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities

Exchange Act of 1934

 

Date of Report (Date of earliest event reported): January 22, 2004

 

MICROSEMI CORPORATION

(Exact name of Registrant as specified in its charter)

 

Delaware    0-8866   95-2110371

(State or other jurisdiction

of incorporation)

   (Commission File Number)  

(I.R.S. Employer

Identification No.)

 

2381 Morse Avenue, Irvine, California    92614
(Address of principal executive office)    (Zip Code)

 

Registrant’s telephone number, including area code (949) 221-7100

 

Not Applicable

(Former name or former address, if changed, since last report)

 



Item 7.   Financial Statements, Pro Forma Financial Information and Exhibits

 

(c) Exhibits.

 

99.1 News Release dated January 22, 2004 relating to the Registrant’s earnings

 

Item 9.   Regulation FD Disclosure.

 

(This information is furnished pursuant to this Item 9 and Item 12. Results of Operations and Financial Condition)

 

On January 22, 2004 , the Registrant is publicly issuing a News Release, which is attached hereto as Exhibit 99.1 and incorporated herein by reference, relating to the Registrant’s earnings.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

       

MICROSEMI CORPORATION

                (Registrant)

Date: January 22, 2004

      By:  

/s/    DAVID R. SONKSEN

         
               

David R. Sonksen,

Executive Vice President,

Chief Financial Officer,

Treasurer and Secretary

EX-99.1 3 dex991.htm NEWS RELEASE ON JANUARY 22, 2004 News Release on January 22, 2004

EXHIBIT 99.1

 

FINANCIAL CONTACT: David R. Sonksen

Executive Vice President and Chief Financial Officer

Tel: (949) 221-7101

 

EDITORIAL CONTACT: Cliff Silver

Manager, Corporate Communications

Tel: (949) 221-7112

 

P R E S S   R E L E A S E

 

Microsemi Reports Fiscal 2004 First Quarter Results

 

  First Quarter Pro Forma EPS of $0.11 Per Share Beats First Call Consensus Guidance of $0.09 Per Share
  Net Sales in First Quarter Increase 4% over Fourth Quarter
  Pro Forma Gross Margins Increase 230 Basis Points over Fourth Quarter
  GAAP Gross Margins Increase 190 Basis Points over Fourth Quarter
  Pro Forma Net Income Increases 50% over Fourth Quarter
  GAAP Net Income Increases 50% over Fourth Quarter

 

Irvine, CA – (BusinessWire) – January 22, 2004—Microsemi Corporation (Nasdaq: MSCC) today reported results for its fiscal year 2004 first quarter ended December 28, 2003.

 

For the first quarter, net sales were $54.9 million, an increase of 20% from net sales of $45.9 million in the year-ago first quarter and an increase of 4% from net sales of $52.8 million in the fourth quarter of fiscal year 2003. First quarter pro forma net income was $3.3 million, or $0.11 per share diluted, up from $0.2 million, or $0.01 per share diluted, in the year-ago first quarter and up 50% from the $2.2 million, or $0.07 per share diluted, in the fourth quarter of fiscal year 2003. Pro forma gross margins for the first quarter were 35.1%, a 230 basis point improvement over the fourth quarter pro forma gross margin of 32.8% and a 390 basis point improvement over the 31.2% pro forma gross margin in the year ago first quarter. The improvement in gross margin in the first quarter resulted from: 1) higher gross margins on new products; 2) improved factory utilization; 3) cost savings resulting from Phase I of our consolidations program; and 4) increased revenues.

 

President and CEO James J. Peterson stated “Due to continuing strength in our markets our results again exceeded analyst expectations and continue to demonstrate successful execution of our plans.”

 

For the first quarter, Microsemi reported GAAP earnings of $2.4 million, or $0.08 per diluted share, compared to earnings of $1.6 million, or $0.05 per diluted share, in the fourth quarter of fiscal year 2003 and compared to a loss of $16.3 million, or $0.56 per share diluted, in the year-ago first quarter. As detailed in the attached “Schedule Reconciling GAAP Earnings to Pro Forma Earnings,” the GAAP loss for last year’s first quarter (fiscal year 2003) included the transition year impairment of goodwill of $14.7 million after tax, for the cumulative effect of a change in accounting principle, retroactively to September 30, 2002, in accordance with the adoption last year of SFAS 142 “Goodwill and Other Intangible Assets,” as well as amortization of acquisition related intangible assets, restructuring costs and other special charges and credits, all of which were excluded in our determination of pro forma amounts.

 

The book-to-bill ratio for the quarter was 1.06.


Business Outlook

 

The Company’s current outlook for net sales in the second quarter of fiscal year 2004 is 3 to 5 percent greater than the net sales in the first quarter. Pro forma earnings per share diluted for the second quarter are currently expected to be $0.12 to $0.14. The gross margin percentage for the second quarter is expected to increase 70 to 120 basis points over the first quarter. Excluding the effect of any restructuring charges from our consolidation program, earnings in the second quarter of fiscal year 2004, in accordance with GAAP, are expected to be $0.11 to $0.13 per share diluted, including a $0.2 million after-tax charge for amortization of acquisition-related intangible assets.

 

About Microsemi

 

Microsemi is a leading designer, manufacturer and marketer of high performance analog and mixed-signal integrated circuits and high reliability discrete semiconductors. The company’s semiconductors manage and control or regulate power, protect against transient voltage spikes and transmit, receive and amplify signals.

 

Microsemi’s products include individual components as well as integrated circuit solutions that enhance customer designs by improving performance and reliability, battery optimization, reducing size or protecting circuits. The principal markets the company serves include implanted medical, defense/aerospace, notebook computers and monitors, automotive and mobile connectivity applications.

 

More information may be obtained by contacting the company directly or by visiting its web site at http://www.microsemi.com.

 

PLEASE READ THE FOLLOWING FACTORS THAT CAN MATERIALLY AFFECT MICROSEMI’S FUTURE RESULTS.

 

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: Any statements set forth in the news release that are not entirely historical and factual in nature are forward-looking statements. For instance, all statements of belief and expectations are forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Potential risks and uncertainties include, but are not limited to, such factors as the difficulties regarding the making of estimates and projections, the hiring and retention of qualified personnel in a competitive labor market, acquiring and integrating new operations or assets, closing or disposing of operations or assets, rapidly changing technology and product obsolescence, the potential inability to realize cost savings or productivity gains and to improve capacity utilization, potential cost increases, weakness or competitive pricing environment of the marketplace, uncertain demand for and acceptance of the company’s products, results of in-process or planned development or marketing and promotional campaigns, changes in demand for products, difficulties foreseeing future demand, effects of limited visibility of future sales, potential non-realization of expected orders or non-realization of backlog, product returns, product liability, and other potential unexpected business and economic conditions or adverse changes in current or expected industry conditions, business disruptions, epidemics, disasters, wars or potential future effects of the tragic events of September 11, variations in customer order preferences, fluctuations in market prices of the company’s common stock and potential unavailability of additional capital on favorable terms, difficulties in implementing company strategies, dealing with environmental matters or litigation, difficulties in determining and maintaining adequate insurance coverage, difficulties protecting patents and other proprietary rights, inventory obsolescence and customer qualification of products, manufacturing facilities and processes. In addition to these factors and any other factors mentioned elsewhere in this news release, the reader should refer as well to the factors, uncertainties or risks identified in the company’s most recent Form 10-K filed on December 19, 2003 by Microsemi with the Securities and Exchange Commission. Additional risk factors may be identified from time to time in Microsemi’s future filings. Microsemi does not undertake to supplement or correct any information in this release that is or becomes incorrect.

 

Investor Inquiries: David R. Sonksen, Microsemi Corporation, Irvine, CA (949) 221-7101.

 

(Financial Tables Follow)


MICROSEMI CORPORATION

Pro Forma Consolidated Income Statements

(In thousands, except per share amounts)

 

     Quarter ended

    

December 29,

2002


   

December 28,

2003


      

NET SALES

   $ 45,869     $ 54,945

Cost of sales

     31,579       35,643
    


 

GROSS MARGIN

     14,290       19,302

Operating expenses:

              

Selling, general and administrative

     9,017       9,707

Research and development

     4,963       4,750
    


 

Total operating expenses

     13,980       14,457
    


 

OPERATING INCOME

     310       4,845

Interest and other income (expense), net

     (60 )     90
    


 

INCOME BEFORE INCOME TAXES

     250       4,935

Provision for income taxes

     82       1,629
    


 

PRO FORMA NET INCOME

   $ 168     $ 3,306

Pro Forma Earnings per share:

              

Basic

   $ 0.01     $ 0.11

Diluted

   $ 0.01     $ 0.11

Common and common equivalent shares outstanding:

              

Basic

     28,905       29,190

Diluted

     29,150       30,701

 

- more -


MICROSEMI CORPORATION

Schedule Reconciling GAAP Earnings to Pro Forma Earnings

(in thousands, except per share amounts)

 

     Quarter Ended

 
    

December 29,

2002


   

December 28,

2003


 
      

GAAP NET INCOME (LOSS)

   $ (16,295 )   $ 2,354  

The pro forma amounts have been adjusted to exclude the following items:

                

Amortization of intangible assets

     (323 )     (302 )

Restructuring charges:

                

Inventory write-off

     (200 )*     —    

Workforce reduction

     (686 )     —    

Facility and asset abandonment

     (477 )*     —    

Facilitation costs

     —         (710 )*

Excess manufacturing cost

     (584 )*     (410 )*

Goodwill impairment

     (22,705 )     —    

Non-recurring loss on sale of asset

     (428 )     —    
    


 


       (25,403 )     (1,422 )

Income tax effect

     8,940       470  
    


 


Net effect of adjustments to GAAP net income

     (16,463 )     (952 )
    


 


PRO FORMA NET INCOME

   $ 168     $ 3,306  
    


 


* Items affecting cost of sales

                

Adjustment to earnings (loss) per share:

                

Basic

   $ (0.57 )   $ (0.03 )

Diluted

   $ (0.57 )   $ (0.03 )

Common and common equivalent shares outstanding:

                

Basic

     28,905       29,190  

Diluted

     28,905       30,701  

 

To supplement the consolidated financial results prepared under generally accepted accounting principles (“GAAP”), Microsemi uses a non-GAAP or pro forma measure of net income that equals GAAP net income adjusted to exclude certain costs, expenses and gains. Pro forma net income gives an indication of Microsemi’s baseline performance in regard to the operating results before gains, losses or other charges that are considered by management to be outside of Microsemi’s core operating results. In addition, pro forma net income is among the primary indicators management uses as a basis for planning and forecasting future periods. These measures are not in accordance with, or an alternative for, GAAP and may be materially different from pro forma measures used by other companies. Microsemi computes pro forma net income principally by adjusting GAAP net income with the impact of acquisition-related charges, restructuring charges, and non-recurring charges and credits.


MICROSEMI CORPORATION

Unaudited Consolidated Income Statements

(In thousands, except per share amounts)

 

     Quarter ended

    

December 29,

2002


   

December 28,

2003


      

NET SALES

   $ 45,869     $ 54,945

Cost of sales

     32,840       36,763
    


 

GROSS MARGIN

     13,029       18,182

Operating expenses:

              

Selling, general and administrative

     9,017       9,707

Research and development

     4,963       4,750

Amortization of intangible assets

     323       302

Restructuring charges

     686       —  

Loss on sale of asset

     428       —  
    


 

Total operating expenses

     15,417       14,759
    


 

OPERATING INCOME (LOSS)

     (2,388 )     3,423

Interest and other income (expense), net

     (60 )     90
    


 

INCOME (LOSS) BEFORE INCOME TAXES

     (2,448 )     3,513

Provision (benefit) for income taxes

     (808 )     1,159
    


 

Income (loss) before cumulative effect of a change in accounting principle

     (1,640 )     2,354

Cumulative effect of a change in accounting principle, net of income taxes

     (14,655 )     —  
    


 

NET INCOME (LOSS)

   $ (16,295 )   $ 2,354
    


 


Basic and Diluted earnings (loss) per share:

              

Earnings (loss) before cumulative effect of a change in accounting principle

   $ (0.05 )   $ 0.08

Cumulative effect of a change in accounting principle

   $ (0.51 )   $ —  
    


 

Earnings (loss) per share

   $

(0.56

)

  $

0.08

Common and common equivalent shares outstanding:

              

Basic

     28,905       29,190

Diluted

     28,905       30,701

 

- more -


MICROSEMI CORPORATION

Condensed Unaudited Consolidated Balance Sheets

(in thousands)

 

    

September 28,

2003


  

December 28,

2003


       

ASSETS

             

Current Assets:

             

Cash and cash equivalents

   $ 29,353    $ 35,617

Accounts receivable, net

     28,866      28,874

Inventories

     53,679      53,759

Deferred income taxes

     5,239      5,239

Other Current assets

     1,234      1,507
    

  

Total current assets

     118,371      124,996

Property and equipment, net

     62,973      61,992

Deferred income taxes

     10,162      10,162

Goodwill

     3,258      3,258

Other intangible assets, net

     6,622      6,319

Other assets

     4,257      4,316
    

  

TOTAL ASSETS

   $ 205,643    $ 211,043
    

  

LIABILITIES AND SHAREHOLDERS’ EQUITY

             

Current liabilities

   $ 31,203    $ 32,432

Long-term debt

     449      436

Other long-term liabilities

     4,131      4,067

Shareholders’ equity

     169,860      174,108
    

  

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

   $ 205,643    $ 211,043
    

  

 

# # # # #

-----END PRIVACY-ENHANCED MESSAGE-----